Canadian Association of Physicians for the Environment
CAPE protects human and environmental health
through education and advocacy. Its members are
doctors and concerned citizens across Canada.
Gideon Forman was there to save us from Lawn Pesticides. Where is he saving our children from HORMONE DISRUPTION DOCTORS? Oh yes, he has a new job. The David Suzuki Foundation is saving us from building a Highway 413 in Toronto, Canada. Shutting down the Alberta Canada Pipelines, Banning Liquified Natural Gas in Canada, Promoting and redirecting Taxpayer Funding to the Registered Nurses Association of Ontario. All from the comfort of 215 Spadina Ave Toronto Canada. Home of Dominion Voting Systems.
He Used the Canadian Paediatric Society as a Scientific Reference Point to argue Pesticides on Lawns are dangerous. The CPS is not looking out for our children’s best interests. It is all about the MONEY.
Health Risks of Pesticides
Two key studies
Journal of The Canadian Paediatric Society 2006:
– health effects of the common weed-killer 2,4-D.
– It found 2,4-D can be “persuasively linked to cancers,
neurological impairment and reproductive problems.”
Canadian Paediatric Society 2023 Position Statement on Hormone Blocker to stop Puberty in the same children they saved from CANCER, they say caused by Lawn Pesticides.
Also referred to as puberty blockers or hormone-suppressing agents, hormone blockers are medications that mitigate the effects of endogenously produced sex steroids. Hormone blockers commonly prescribed in Canada, and key considerations for their use are reviewed in Table 6. Hormone blockers can suppress sex steroid-mediated experiences, such as menses (for AFAB youth) or erections (for AMAB youth), and pause or slow sex steroid-related physical changes that continue into young adulthood. Gonadotropin-releasing hormone agonists (GnRHa) are hormone blockers that, if started before pubertal development is complete, will pause pubertal progression. Hormonal suppression is reversible, and endogenous sex-steroid production and/or effects will resume if hormone blockers are discontinued–.
Initially, the clinical objective of prescribing a hormone blocker is to provide a young person with time to further explore their gender identity without pressure or distress related to ongoing development of secondary sex characteristics, or gendered experiences such as menses or erectionshttps://cps.ca/en/documents/position/an-affirming-approach-to-caring-for-transgender-and-gender-diverse-youth